Internal Medicine, Hematology & Oncology · Fresno, CA
NPI
1295961480
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
7300 N Fresno St
Fresno, CA, 93720
Phone (559) 448-4500
Groups this clinician bills Medicare through
Medicare paid, 2022
$13K
480 services
Medicare patients, 2022
18
Average age 70
Drug cost, 2024
$4.0M
1,268 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Gabriel A Rivera prescribed most often to Medicare patients was Anastrozole, with 116 prescriptions and refills. In total Gabriel A Rivera wrote 1,268 Medicare prescriptions that cost $4.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 116 | 311 | 51 | $2,935 |
| Dexamethasone Generic | 88 | 93 | 36 | $1,131 |
| Ondansetron Hcl Generic | 60 | 65 | 37 | $544 |
| Prednisone Generic | 53 | 69 | 28 | $486 |
| Prochlorperazine Maleate Generic | 52 | 52 | 36 | $744 |
| Ibrance Palbociclib | 50 | 50 | Under 11 | $776K |
| Abiraterone Acetate Generic | 43 | 60 | 18 | $8,020 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 41 | 41 | 25 | $2,120 |
| Lenalidomide Generic | 40 | 40 | Under 11 | $473K |
| Brukinsa Zanubrutinib | 37 | 37 | Under 11 | $394K |
| Tamoxifen Citrate Generic | 35 | 109 | 16 | $900 |
| Tagrisso Osimertinib Mesylate | 32 | 32 | Under 11 | $544K |
| Nivestym Filgrastim-Aafi | 30 | 30 | Under 11 | $15K |
| Olanzapine Generic | 23 | 27 | 18 | $149 |
| Granix Tbo-Filgrastim | 21 | 21 | Under 11 | $9,659 |
Brand drugs: - claims; generic drugs: 943 claims; opioid claims: 97.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Gabriel A Rivera were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.